CN109553585A - A kind of synthetic method of 3- chloromethyl -1,2,4- triazoline -5- ketone - Google Patents

A kind of synthetic method of 3- chloromethyl -1,2,4- triazoline -5- ketone Download PDF

Info

Publication number
CN109553585A
CN109553585A CN201811639765.4A CN201811639765A CN109553585A CN 109553585 A CN109553585 A CN 109553585A CN 201811639765 A CN201811639765 A CN 201811639765A CN 109553585 A CN109553585 A CN 109553585A
Authority
CN
China
Prior art keywords
ketone
chloromethyl
triazoline
synthetic method
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811639765.4A
Other languages
Chinese (zh)
Inventor
吴生文
李锋莉
胡四明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHIRAL QUEST BIOCHEMICAL (SUZHOU) CO LTD
Original Assignee
CHIRAL QUEST BIOCHEMICAL (SUZHOU) CO LTD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHIRAL QUEST BIOCHEMICAL (SUZHOU) CO LTD filed Critical CHIRAL QUEST BIOCHEMICAL (SUZHOU) CO LTD
Priority to CN201811639765.4A priority Critical patent/CN109553585A/en
Publication of CN109553585A publication Critical patent/CN109553585A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms

Abstract

The present invention relates to a kind of 3- chloromethyl -1,2, the synthetic method of 4- triazoline -5- ketone is mixed with using chloroacetonitrile, alcohol and solvent A, and compared with traditional handicraft, the present invention has selected the lower raw material of price, significantly reduces production cost.For entire process flow, present invention reduces synthetic routes, improve production efficiency.While simplifying production technology, the operation and quality control of production are easily facilitated.

Description

A kind of synthetic method of 3- chloromethyl -1,2,4- triazoline -5- ketone
Technical field
The present invention relates to a kind of synthetic method more particularly to a kind of 3- chloromethyl -1,2, the synthesis sides of 4- triazoline -5- ketone Method.
Background technique
Aprepitant (Aprepitant), entitled 5- [[(2R, 3S) -2- [(1R) -1- [3,5- bis- (trifluoromethyls) of chemistry Phenyl] ethyoxyl] -3- (4- fluorophenyl) -4- morpholinyl] methyl] -1,2- dihydro -3H-1,2,4- triazole -3- ketone, are the U.S. Neurokinine-1 (NK-1) receptor antagonist of Merck&Co company research and development is ratified to list, is used for for 2003 through U.S. FDA Prevention is high to be caused acute caused by spitting property antineoplastic chemotherapy medicine (including High-dose Cisplatin Chemotherapy therapeutic scheme) and Delayed onset nausea, vomits It spits.Aprepitant can pass through blood-brain barrier, play antiemetic effect [Huang Donglin .2003 with brain nk 1 receptor selective binding The Shanghai new drug [J] the medicine of U.S.'s approval, 2004,25 (9): 418-422], [Nie Ying, Bi little Ling, You Qidong aprepitant [J] Chinese Journal of New Drugs, 2006,15 (3): 238-239].
In view of the above shortcomings, the designer, is actively subject to research and innovation, to found a kind of 3- chloromethyl -1,2, The synthetic method of 4- triazoline -5- ketone makes it with more the utility value in industry.
Summary of the invention
In order to solve the above technical problems, the object of the present invention is to provide a kind of 3- chloromethyl -1,2,4- triazoline -5- ketone Synthetic method.
A kind of 3- chloromethyl -1,2 of the invention, the synthetic method of 4- triazoline -5- ketone comprising following steps: (1) chlorine Acetonitrile, alcohol and solvent A mixing, are passed through HCl gas while stirring under conditions of 0.5 to 10 DEG C, 5 to 25 are reacted after ventilation Hour, imino group chloroethyl alkyl ether hydrochloride is obtained after purification;(2) solvent B is warming up to 50 DEG C, the imino group chloroethene is added Base alkyl ether hydrochloride, reaction are cooled to -10 to 3 DEG C after 1 to 7 hour, filter to take filtrate, which is warming up to 15 to 45 again DEG C, semicarbazide hydrochloride is added, reacts 24 to 82 hours, obtains 3- chloromethyl -1,2,4- triazoline -5- ketone;
Wherein, the alcohol is the single hydroxyl alcohol of the alkyl containing 1~6 carbon atom;The moisture content of the preparation of the alcohol is 0.3% or less;The solvent A is methyl tertiary butyl ether(MTBE) or methylene chloride;The solvent B is methanol or ethyl alcohol;The chloroacetonitrile, The molar ratio of alcohol, HCl and semicarbazide hydrochloride is 1:1~1.05:1.025~1.1:0.275~0.22175.
Further, above-mentioned 3- chloromethyl -1,2, the synthetic method of 4- triazoline -5- ketone, wherein the alcohol is methanol Or ethyl alcohol.
Further, above-mentioned 3- chloromethyl -1,2, the synthetic method of 4- triazoline -5- ketone, wherein the alcohol formulations Moisture content be 0.05% or less.
Further, above-mentioned 3- chloromethyl -1,2, the synthetic method of 4- triazoline -5- ketone, wherein the chloroacetonitrile The mass ratio that feeds intake with solvent A is 1:5~12.
Further, above-mentioned 3- chloromethyl -1,2, the synthetic method of 4- triazoline -5- ketone, wherein the imino group The mass ratio that feeds intake of chloroethyl alkyl ether hydrochloride and solvent B are 1:0.34~2.34.
Further, above-mentioned 3- chloromethyl -1,2, the synthetic method of 4- triazoline -5- ketone, wherein the 3- chloromethane The purifying of base -1,2,4- triazoline -5- ketone is the following steps are included: the 3- chloromethyl -1,2,4- triazole that the step (2) obtains Filtrate a, the filtrate a is taken to be evaporated under reduced pressure after the filtering of quinoline -5- ketone in 50 DEG C, solvent C, heating stirring reflux is added in obtained solid 30min filters to take filtrate b while hot, and the filtrate b cooling crystallization obtains filter residue c after filtering, the filter residue c be dried in vacuo 3- chloromethyl -1,2,4- triazoline -5- the ketone of white powder;Wherein, the solvent C is isopropanol or acetone.
Further, above-mentioned 3- chloromethyl -1,2, the synthetic method of 4- triazoline -5- ketone, wherein the semicarbazides Hydrochloride and the mass ratio that feeds intake of solvent C are 1:6~12.
Further, above-mentioned 3- chloromethyl -1,2, the synthetic method of 4- triazoline -5- ketone, wherein the cooling analysis Brilliant temperature is -15 to 35 DEG C.
Still further, above-mentioned 3- chloromethyl -1,2, the synthetic method of 4- triazoline -5- ketone, wherein the vacuum is dry Dry temperature is 25 to 70 DEG C.
The above description is only an overview of the technical scheme of the present invention, in order to better understand the technical means of the present invention, And can be implemented in accordance with the contents of the specification, with presently preferred embodiments of the present invention, detailed description is as follows below.
Specific embodiment
With reference to embodiment, the embodiment of the present invention is furthur described in detail.Following embodiment is used for Illustrate the present invention, but is not intended to limit the scope of the invention.
Embodiment 1
Chloroacetonitrile 30.2g (0.4mol), methanol (moisture content 0.08%) 13.4g are put into magnetic agitation reactor (0.42mol) and methyl tertiary butyl ether(MTBE) 300g, for cooling down to 0 DEG C, control is slowly equably passed through drying below the temperature HCl gas 15g (0.41mol), after ventilation, be stirred to react 20h, it is seen that there are a large amount of white needle-like crystals to generate;Filtering Filter residue is taken to get imino group chloroethyl methyl ether hydrochloride is arrived.Methanol 120g is placed in reaction kettle, stirring is warming up to 50 DEG C, Then the imino group chloroethyl methyl ether hydrochloride 55g is added, and maintains 40 lower DEG C and is stirred to react 4 hours;Reaction solution stirs It mixes and is cooled to 0 DEG C, filter;Filtrate stirring is warming up to 20 DEG C, is added semicarbazide hydrochloride 7.7g (0.07mol), and maintain the temperature It is stirred to react under degree 72 hours;Reaction solution filtering, filtrate are concentrated to dryness in 50 DEG C~50 DEG C, and isopropanol is added in obtained solid 77g, heating stirring reflux 30min, filters to take filtrate, which obtains white needle crystals, i.e., in 0 DEG C of cooling crystallization while hot For 3- chloromethyl -1,2,4- triazoline -5- ketone, filtering, be dried in vacuo in 50 DEG C white powder chloromethyl -1 solid 3-, 2,4- triazoline -5- ketone 5.3g, total moles yield (in terms of semicarbazide hydrochloride) are 57%, HPLC purity 99.6%, fusing point 181 DEG C~183 DEG C.
Embodiment 2
Chloroacetonitrile 60.4g (0.8mol), ethyl alcohol (moisture content 0.06%) 36.8g are put into magnetic agitation reactor (0.8mol) and methylene chloride 400g, for cooling down to 5 DEG C, control is slowly equably passed through dry HCl below the temperature Gas 32g (0.88mol), after ventilation, is stirred to react 10h, it is seen that has a large amount of white needle-like crystals to generate;Filter to take filter Slag to get arrive imino group chloroethylethyl ether hydrochloride.Ethyl alcohol 300g is placed in reaction kettle, stirring is warming up to 50 DEG C, then The imino group chloroethyl methyl ether hydrochloride 128g is added, and maintains 45 lower DEG C and is stirred to react 6 hours;Reaction solution stirring drop Temperature is filtered to -5 DEG C;Filtrate stirring is warming up to 40 DEG C, is added semicarbazide hydrochloride 15.5g (0.14mol), and maintain the temperature Under be stirred to react 35 hours;Reaction solution filtering, filtrate are concentrated to dryness in 50 DEG C~50 DEG C, and acetone is added in obtained solid 150g, heating stirring reflux 30min, filters to take filtrate while hot, which is placed in -5 DEG C of cooling crystallizations, and it is brilliant to obtain white fine acicular Body, as 3- chloromethyl -1,2,4- triazoline -5- ketone, filtering, be dried in vacuo in 55 DEG C white powder solid 3- chloromethane Base -1,2,4- triazoline -5- ketone 11.5g, total moles yield (in terms of semicarbazide hydrochloride) are 62%, HPLC purity 99.5%, 181 DEG C~183 DEG C of fusing point.
Embodiment 3
Chloroacetonitrile 3.02kg (40mol), methanol (moisture content 0.05%) are put into mechanically stirred reactor 1.28kg (40mol) and methyl tertiary butyl ether(MTBE) 33kg, to 2 DEG C, control is slowly equably passed through cooling down below the temperature Dry HCl gas 1.6kg (44mol), after ventilation, is stirred to react 15h, it is seen that has a large amount of white needle-like crystals to generate; Filter residue is filtered to take to get imino group chloroethyl methyl ether hydrochloride is arrived.Methanol 18kg is placed in reaction kettle, stirring is warming up to 50 DEG C, the imino group chloroethyl methyl ether hydrochloride 6.1kg is then added, and maintain 45 lower DEG C and be stirred to react 2.5 hours;Instead It answers liquid stirring to be cooled to 0 DEG C, filters;Filtrate stirring is warming up to 20 DEG C, is added semicarbazide hydrochloride 0.9kg (8.07mol), and tie up It holds and is stirred to react at this temperature 70 hours;Reaction solution filtering, filtrate are concentrated to dryness in 50 DEG C~50 DEG C, and obtained solid is added Isopropanol 6.5kg, heating stirring reflux 30min, filters to take filtrate, which is placed in 5 DEG C of cooling crystallizations, obtains white fine needle while hot Shape crystal, as 3- chloromethyl -1,2,4- triazoline -5- ketone, filtering, be dried in vacuo in 50 DEG C white powder solid 3- Chloromethyl -1,2,4- triazoline -5- ketone 0.64kg, total moles yield (in terms of semicarbazide hydrochloride) are 60%, HPLC purity 99.3%, 181 DEG C~183 DEG C of fusing point.
It can be seen that after applying the present invention by above-mentioned character express, gather around and have the following advantages:
1, compared with traditional handicraft, the present invention has selected the lower raw material of price, significantly reduces production cost.
2, for entire process flow, present invention reduces synthetic routes, improve production efficiency.
3, while simplifying production technology, the operation and quality control of production are easily facilitated.
The above is only a preferred embodiment of the present invention, it is not intended to restrict the invention, it is noted that for this skill For the those of ordinary skill in art field, without departing from the technical principles of the invention, can also make it is several improvement and Modification, these improvements and modifications also should be regarded as protection scope of the present invention.

Claims (9)

1. a kind of 3- chloromethyl -1,2, the synthetic method of 4- triazoline -5- ketone, it is characterised in that the following steps are included: (1) chloroethene Nitrile, alcohol and solvent A mixing, are passed through HCl gas while stirring under conditions of 0.5 to 10 DEG C, and it is small that 5 to 25 are reacted after ventilation When, imino group chloroethyl alkyl ether hydrochloride is obtained after purification;(2) solvent B is warming up to 50 DEG C, the imino group chloroethyl is added Alkyl ether hydrochloride, reaction are cooled to -10 to 3 DEG C after 1 to 7 hour, filter to take filtrate, which is warming up to 15 to 45 DEG C again, Semicarbazide hydrochloride is added, reacts 24 to 82 hours, obtains 3- chloromethyl -1,2,4- triazoline -5- ketone;
Wherein, the alcohol is the single hydroxyl alcohol of the alkyl containing 1~6 carbon atom;The moisture content of the preparation of the alcohol is 0.3% Below;The solvent A is methyl tertiary butyl ether(MTBE) or methylene chloride;The solvent B is methanol or ethyl alcohol;The chloroacetonitrile, alcohol, The molar ratio of HCl and semicarbazide hydrochloride is 1:1~1.05:1.025~1.1:0.275~0.22175.
2. 3- chloromethyl -1,2 as described in claim 1, the synthetic method of 4- triazoline -5- ketone, it is characterised in that: the alcohol For methanol or ethyl alcohol.
3. 3- chloromethyl -1,2 as described in claim 1, the synthetic method of 4- triazoline -5- ketone, it is characterised in that: the alcohol The moisture content of preparation is 0.05% or less.
4. 3- chloromethyl -1,2 as described in claim 1, the synthetic method of 4- triazoline -5- ketone, it is characterised in that: the chlorine The mass ratio that feeds intake of acetonitrile and solvent A is 1:5~12.
5. 3- chloromethyl -1,2 as described in claim 1, the synthetic method of 4- triazoline -5- ketone, it is characterised in that: the Asia The mass ratio that feeds intake of amino chloroethyl alkyl ether hydrochloride and solvent B are 1:0.34~2.34.
6. 3- chloromethyl -1,2 as described in claim 1, the synthetic method of 4- triazoline -5- ketone, which is characterized in that the 3- The purifying of chloromethyl -1,2,4- triazoline -5- ketone is the following steps are included: the 3- chloromethyl -1,2,4- three that the step (2) obtains Filtrate a, the filtrate a is taken to be evaporated under reduced pressure after the filtering of oxazoline -5- ketone in 50 DEG C, solvent C, heating stirring reflux is added in obtained solid 30min filters to take filtrate b while hot, and the filtrate b cooling crystallization obtains filter residue c after filtering, the filter residue c be dried in vacuo 3- chloromethyl -1,2,4- triazoline -5- the ketone of white powder;Wherein, the solvent C is isopropanol or acetone.
7. 3- chloromethyl -1,2 as claimed in claim 6, the synthetic method of 4- triazoline -5- ketone, it is characterised in that: the ammonia Base urea hydrochloride and the mass ratio that feeds intake of solvent C are 1:6~12.
8. 3- chloromethyl -1,2 as claimed in claim 6, the synthetic method of 4- triazoline -5- ketone, it is characterised in that: described cold But the temperature of crystallization is -15 to 35 DEG C.
9. 3- chloromethyl -1,2 as claimed in claim 6, the synthetic method of 4- triazoline -5- ketone, it is characterised in that: described true The dry temperature of sky is 25 to 70 DEG C.
CN201811639765.4A 2018-12-29 2018-12-29 A kind of synthetic method of 3- chloromethyl -1,2,4- triazoline -5- ketone Pending CN109553585A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811639765.4A CN109553585A (en) 2018-12-29 2018-12-29 A kind of synthetic method of 3- chloromethyl -1,2,4- triazoline -5- ketone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811639765.4A CN109553585A (en) 2018-12-29 2018-12-29 A kind of synthetic method of 3- chloromethyl -1,2,4- triazoline -5- ketone

Publications (1)

Publication Number Publication Date
CN109553585A true CN109553585A (en) 2019-04-02

Family

ID=65871976

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811639765.4A Pending CN109553585A (en) 2018-12-29 2018-12-29 A kind of synthetic method of 3- chloromethyl -1,2,4- triazoline -5- ketone

Country Status (1)

Country Link
CN (1) CN109553585A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004017898A2 (en) * 2002-08-21 2004-03-04 Merck & Co., Inc. Process for preparing 3-chloromethyl-1,2,4-triazolin-5-one
CN1906155A (en) * 2003-12-03 2007-01-31 利奥制药有限公司 Novel hydroxamic acid esters and pharmaceutical use thereof
CN104628663A (en) * 2013-11-08 2015-05-20 中山奕安泰医药科技有限公司 Synthesis method of 3-chloromethyl-1,2,4-triazoline-5-one

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004017898A2 (en) * 2002-08-21 2004-03-04 Merck & Co., Inc. Process for preparing 3-chloromethyl-1,2,4-triazolin-5-one
CN1906155A (en) * 2003-12-03 2007-01-31 利奥制药有限公司 Novel hydroxamic acid esters and pharmaceutical use thereof
CN104628663A (en) * 2013-11-08 2015-05-20 中山奕安泰医药科技有限公司 Synthesis method of 3-chloromethyl-1,2,4-triazoline-5-one

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CAMERON J COWDEN,等: "A new synthesis of 1,2,4-triazolin-5-ones: application to the convergent synthesis of an NK1 antagonist", 《TETRAHEDRON LETTERS》 *

Similar Documents

Publication Publication Date Title
CN102167695B (en) Benzimidazole-carbonyl-pyridine-amino-ehtyl-propionate hemihyrate and its use
CN104837818B (en) It can be used as the acid amides of pyridine 2 of CB2 activators
EA011407B1 (en) Hydrates and polymorphs of 4-[[(7r)-8cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl]amino]-3-methoxy-n-(1-methyl-4-piperidinyl) benzamide, methods for the production thereof, and use thereof as medicaments
CN1486184A (en) Lactam compound to inhibit beta-amyloid peptide release or synthesis
CN104788438B (en) The net B crystal forms of En Gelie and its preparation
WO2011113203A1 (en) Deuterium-substituted omega-diphenylurea and derivatives thereof and pharmaceutical compositions comprising the compounds
CN103649104A (en) Process for the preparation of fluticasone propionate form 1
CN109553585A (en) A kind of synthetic method of 3- chloromethyl -1,2,4- triazoline -5- ketone
CN104829673B (en) A kind of preparation method of rope fluorine cloth Wei crystal formation 6
CN109503392A (en) A kind of synthetic method of (S) -3- amino -3- (4- chlorphenyl) -1- propyl alcohol
CN104628663A (en) Synthesis method of 3-chloromethyl-1,2,4-triazoline-5-one
CN104628677A (en) Crystal forms of vortioxetine organic acid salt and preparation method thereof
CN110183391A (en) The method that one kettle way prepares D-Cycloserine
US11339119B2 (en) Crystal form and amorphous form of dezocine analogue hydrochloride
CN107001284B (en) A kind of crystal form and preparation method thereof of androgen receptor inhibitor
CN109232582A (en) La Luo is for Buddhist nun's disulfate crystal form and its preparation and application
CN105330664B (en) A kind of synthetic method of Xi Gelieting impurity
CN105254590B (en) Vortioxetine hydrobromate crystal form and its preparation method and application
CN107663173A (en) Miscellaneous Shandong amine of grace and its production and use
CA2452253C (en) Novel crystal of arylethenesulfonamide derivative and preparation process thereof
US8754129B2 (en) Crystalline vorinostat form VI
CN110078679A (en) A kind of lamotrigine pharmaceutical co-crystal and its preparation method and application
CN108864048A (en) A kind of preparation method of dabigatran etexilate methanesulfonate
CN105859748B (en) Polycyclic compound sodium salt and its polymorphic, preparation method and application
CN104203915A (en) (3,4-dichloro-phenyl)-((s)-3-propyl-pyrrolidin-3-yl)-methanone hydrochloride and manufacturing processes

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190402

RJ01 Rejection of invention patent application after publication